Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index; 23 of the 57 sources its claims cite were checked for support.

A randomised controlled trial of acceptance and commitment therapy plus usual care compared to usual care alone for improving psychological health in people with motor neuron disease (COMMEND): study protocol.

Open access

Abstract

Background: Motor neuron disease (MND) is a rapidly progressive, fatal neurodegenerative disease that predominantly affects motor neurons from the motor cortex to the spinal cord and causes progressive wasting and weakening of bulbar, limb, abdominal and thoracic muscles. Prognosis is poor and median survival is 2-3 years following symptom onset. Psychological distress is relatively common in people living with MND. However, formal psychotherapy is not routinely part of standard care within MND Care Centres/clinics in the UK, and clear evidence-based guidance on improving the psychological health of people living with MND is lacking. Previous research suggests that Acceptance and Commitment Therapy (ACT) may be particularly suitable for people living with MND and may help improve their psychological health.Aims: To assess the clinical and cost-effectiveness of ACT modified for MND plus usual multidisciplinary care (UC) in comparison to UC alone for improving psychological health in people living with MND.Methods: The COMMEND trial is a multi-centre, assessor-blind, parallel, two-arm RCT with a 10-month internal pilot phase. 188 individuals aged ≥ 18 years with a diagnosis of definite, laboratory-supported probable, clinically probable, or possible familial or sporadic amyotrophic lateral sclerosis, and additionally the progressive muscular atrophy and primary lateral sclerosis variants, will be recruited from approximately 14 UK-based MND Care Centres/clinics and via self-referral. Participants will be randomly allocated to receive up to eight 1:1 sessions of ACT plus UC or UC alone by an online randomisation system. Participants will complete outcome measures at baseline and at 6- and 9-months post-randomisation. The primary outcome will be quality of life at six months. Secondary outcomes will include depression, anxiety, psychological flexibility, health-related quality of life, adverse events, ALS functioning, survival at nine months, satisfaction with therapy, resource use and quality-adjusted life years. Primary analyses will be by intention to treat and data will be analysed using multi-level modelling.Discussion: This trial will provide definitive evidence on the clinical and cost-effectiveness of ACT plus UC in comparison to UC alone for improving psychological health in people living with MND.Trial Registration: ISRCTN Registry, ISRCTN12655391. Registered 17 July 2017, https://www.isrctn.com/ISRCTN12655391 .Protocol Version: 3.1 (10/06/2020).

Overview

CoChat Summary

## TL;DR

This is a study protocol for the COMMEND randomized controlled trial testing acceptance and commitment therapy (ACT) plus usual multidisciplinary care versus usual care alone for people with motor neuron disease (MND). The trial will assess clinical and cost-effectiveness, with the primary outcome being quality of life at 6 months.

## Key findings

  • The planned trial will recruit 188 people aged ≥ 18 years with MND from about 14 UK MND Care Centres/clinics plus self-referral.
  • Participants will be randomized to up to eight 1:1 ACT sessions plus usual care or usual care alone; the primary endpoint is quality of life at 6 months post-randomization.
  • The sample size is powered to detect an effect size of 0.44 standard deviations with 90% power at a 5% two-sided alpha, assuming 20% attrition at 6 months.
  • The protocol states the trial will also examine cost-effectiveness (including quality-adjusted life years) and secondary outcomes such as depression, anxiety, psychological flexibility, adverse events, ALS functioning, survival at 9 months, satisfaction with therapy, and caregiver burden.

## Methods

  • Design: Multi-centre, assessor-blind, parallel, two-arm randomized controlled trial with a 10-month internal pilot phase; allocation is 1:1 stratified by site, and primary analyses are intention to treat using multi-level mixed effects models.
  • Sample/data: 188 adults with definite/laboratory-supported probable/clinically probable/possible familial or sporadic ALS, plus progressive muscular atrophy and primary lateral sclerosis variants; recruitment from approximately 14 UK sites and self-referral. Caregivers can also participate if present, and therapists are study staff delivering the intervention.
  • Intervention/comparison: ACT modified for MND, delivered in up to eight 1:1 sessions over 4 months, versus usual multidisciplinary care as outlined in NICE NG42; outcomes are collected at baseline, 6 months, and 9 months.

## Limitations

  • The paper explicitly states limitations of a non-active control arm, potential unblinding of outcome assessors, and a relatively short follow-up period.
  • It also notes that the short follow-up means the study will not be able to examine longer-term treatment effects.
  • Evident from the protocol: because the intervention is compared with usual care rather than an active psychotherapy control, any benefit may be hard to attribute specifically to ACT rather than non-specific effects such as support; this is stated in the paper.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12883-022-02950-5

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Timeline for plwMND in the trial
Fig. 1 Timeline for plwMND in the trialCC BY · PubMed Central

Verification

Claims the paper makes

13 Valid · 3 Not valid · 17 Not checked · 23 Own results and interpretations

4 more claims

Create a free account to see all 56 claims and to verify the 2 references still open.

See all claims — free account
  • It may state two separate claims as one. 21
  • Probably not a substantial claim. 38

Create a free account to see these claims.

Citations

Cites

Show all 65 references

Research works printed but not linked: 1

  1. Curtis L, Burns A. Unit costs of health and social care 2015. Personal Social Services Research Unit: University of Kent; 2015.

Cited by

See all 16

Metadata

Authors
Gould, R. L., Thompson, B. J., Rawlinson, C., Kumar, P., White, D., Serfaty, M. A., Graham, C. D., McCracken, L. M., Bursnall, M., Bradburn, M., Young, T., Howard, R. J., Al-Chalabi, A., Goldstein, L. H., Lawrence, V., Cooper, C., Shaw, P. J., & McDermott, C. J.
Affiliations
  • University College London (GB)
  • University of Sheffield (GB)
  • Queen's University Belfast (GB)
  • Uppsala University (SE)
  • King's College London (GB)
Corresponding author
Gould, Rebecca L.
Venue
BMC Neurology
Published
2022-11-15
Volume
22
Issue
1
Pages
431-431
ISSN
1471-2377 (ISSN-L)
OpenAlex
W4309323790
Cited by
16
References
65
Citations by year
2026: 3 · 2024: 6 · 2023: 7
FWCI
2.97
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Neurology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • Research Portal (Queen's University Belfast) (acceptedVersion, other-oa)
  • Strathprints: The University of Strathclyde institutional repository (University of Strathclyde) (acceptedVersion, other-oa)
  • Research Portal (King's College London) (acceptedVersion, cc-by)
  • KTH Publication Database DiVA (KTH Royal Institute of Technology) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UCL Discovery (University College London) (submittedVersion)
Funders
  • National Institute for Health and Care Research (16.81.01)
  • Motor Neurone Disease Association (914225)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
Keywords
acceptance and commitment therapy, motor neuron disease, amyotrophic lateral sclerosis, mental health, psychological distress, quality of life, depression, anxiety, psychological flexibility, cost-effectiveness, usual care, progressive muscular atrophy, primary lateral sclerosis, resource utilization (health care), quality-adjusted life years, survival, treatment satisfaction, adverse events
MeSH terms
Cost-Benefit Analysis, Humans, Quality of Life, Randomized Controlled Trials as Topic, Motor Neuron Disease, Neurodegenerative Diseases, Acceptance and Commitment Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A randomised controlled trial of acceptance and commitment therapy plus usual care compared to usual care alone for improving psychological health in people with motor neuron disease (COMMEND): study protocol. https://app.cochat.ai/papers/10.1186/s12883-022-02950-5
The paper
Gould, R. L., Thompson, B. J., Rawlinson, C., Kumar, P., White, D., Serfaty, M. A., Graham, C. D., McCracken, L. M., Bursnall, M., Bradburn, M., Young, T., Howard, R. J., Al-Chalabi, A., Goldstein, L. H., Lawrence, V., Cooper, C., Shaw, P. J., & McDermott, C. J. (2022). A randomised controlled trial of acceptance and commitment therapy plus usual care compared to usual care alone for improving psychological health in people with motor neuron disease (COMMEND): study protocol. BMC Neurology. https://doi.org/10.1186/s12883-022-02950-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.